Clinical trials investigating venetoclax combinations for AML
The benefits of patient advocacy groups
Anti-BCMA CAR T-cells for MM: durable clinical responses with bb2121
Supporting young hematology researchers: training programs offered by EHA and ASH
T-cell engaging antibodies: what lessons have we learnt?